Header Logo

Michael Jelinek

Concepts (241)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Head and Neck Neoplasms
5
2023
151
2.260
Why?
Coronary Disease
9
2015
66
1.660
Why?
Protein Kinase Inhibitors
3
2020
50
1.450
Why?
Cisplatin
2
2023
52
1.410
Why?
Cardiovascular Diseases
6
2020
372
1.340
Why?
Secondary Prevention
5
2020
54
1.280
Why?
Cardiology
5
2021
57
1.240
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2021
241
1.210
Why?
Cardiac Rehabilitation
4
2021
8
1.110
Why?
Lung Neoplasms
3
2021
553
1.080
Why?
Coronary Artery Disease
4
2017
141
0.940
Why?
Acute Coronary Syndrome
4
2021
16
0.870
Why?
Acrylamides
2
2020
3
0.840
Why?
Aniline Compounds
2
2020
36
0.840
Why?
Humans
45
2023
28436
0.780
Why?
Exercise Test
3
2018
122
0.760
Why?
Heart Failure
7
2021
180
0.750
Why?
Carboplatin
1
2021
24
0.730
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2021
5
0.730
Why?
Benzimidazoles
1
2021
9
0.730
Why?
Paclitaxel
1
2021
44
0.720
Why?
Standard of Care
1
2020
13
0.720
Why?
Carcinoma, Non-Small-Cell Lung
2
2021
244
0.690
Why?
Biological Specimen Banks
1
2019
8
0.670
Why?
Antineoplastic Agents, Immunological
1
2019
17
0.650
Why?
Medicine
2
2008
11
0.620
Why?
Physicians, Family
2
2008
6
0.620
Why?
Specialization
2
2008
17
0.620
Why?
Cardiorespiratory Fitness
1
2018
16
0.600
Why?
Lipocalin-2
1
2018
2
0.600
Why?
Cystatin C
1
2018
3
0.600
Why?
Life Style
3
2019
201
0.590
Why?
Mutation
1
2019
353
0.580
Why?
Acute Kidney Injury
1
2018
47
0.580
Why?
Antineoplastic Agents
1
2019
190
0.570
Why?
Hydrocarbons, Fluorinated
1
2017
2
0.560
Why?
Apoptosis
2
2022
205
0.560
Why?
Taxoids
1
2017
10
0.560
Why?
Hypertension
2
2019
246
0.560
Why?
Practice Guidelines as Topic
2
2018
319
0.540
Why?
ErbB Receptors
3
2023
54
0.530
Why?
Cell Proliferation
1
2017
178
0.520
Why?
Aged
20
2023
9277
0.490
Why?
Depression
3
2018
452
0.480
Why?
Neoplasms
1
2018
239
0.480
Why?
Coronary Artery Bypass
1
2014
29
0.460
Why?
Myocardial Ischemia
1
2014
43
0.450
Why?
Patient Education as Topic
2
2013
160
0.450
Why?
Vulnerable Populations
1
2013
27
0.440
Why?
Return to Work
1
2014
65
0.440
Why?
Middle Aged
17
2021
9269
0.430
Why?
Risk Reduction Behavior
1
2013
46
0.430
Why?
Male
20
2023
15291
0.420
Why?
Breast Neoplasms
1
2017
409
0.410
Why?
Female
19
2021
15730
0.390
Why?
Critical Pathways
1
2011
21
0.370
Why?
Program Evaluation
3
2017
137
0.360
Why?
Delivery of Health Care, Integrated
1
2011
25
0.360
Why?
Psychiatric Status Rating Scales
1
2011
326
0.340
Why?
Chest Pain
1
2009
19
0.330
Why?
Risk Factors
11
2019
2408
0.330
Why?
Prognosis
4
2021
825
0.330
Why?
Mass Screening
1
2011
183
0.320
Why?
Australia
8
2021
40
0.320
Why?
Smartphone
2
2021
17
0.320
Why?
Models, Statistical
1
2009
129
0.320
Why?
Medication Adherence
1
2009
84
0.300
Why?
Exercise Therapy
2
2021
98
0.300
Why?
Biomarkers
3
2020
596
0.290
Why?
Young Adult
4
2021
2069
0.280
Why?
Death, Sudden
1
2006
7
0.270
Why?
Quality of Life
4
2021
661
0.260
Why?
Adult
8
2021
8107
0.240
Why?
Prospective Studies
6
2018
1809
0.230
Why?
Risk Assessment
5
2019
677
0.230
Why?
Platelet Aggregation Inhibitors
2
2018
49
0.230
Why?
Prevalence
2
2019
468
0.220
Why?
Cetuximab
1
2023
6
0.210
Why?
Radiotherapy, Intensity-Modulated
1
2023
38
0.210
Why?
Laryngeal Neoplasms
1
2023
32
0.210
Why?
Counseling
2
2017
45
0.200
Why?
Cell-Derived Microparticles
1
2022
8
0.200
Why?
Nose Neoplasms
1
2022
40
0.200
Why?
Paranasal Sinus Neoplasms
1
2022
63
0.190
Why?
Aged, 80 and over
7
2019
4857
0.180
Why?
Radiosurgery
1
2021
38
0.180
Why?
DDT
1
2020
1
0.180
Why?
Insulin-Secreting Cells
1
2020
12
0.180
Why?
Carcinoma, Squamous Cell
1
2022
177
0.170
Why?
Comorbidity
4
2021
500
0.170
Why?
Societies, Medical
2
2020
154
0.170
Why?
Proteomics
1
2020
93
0.170
Why?
United Kingdom
1
2019
51
0.170
Why?
Blood Circulation
1
2019
1
0.170
Why?
Liquid Biopsy
1
2019
2
0.170
Why?
Circulating Tumor DNA
1
2019
5
0.170
Why?
DNA Mutational Analysis
1
2019
59
0.160
Why?
Retrospective Studies
5
2023
3612
0.160
Why?
Walking Speed
1
2019
40
0.160
Why?
France
1
2019
17
0.160
Why?
Diastole
1
2019
32
0.160
Why?
Molecular Targeted Therapy
1
2019
35
0.160
Why?
Waist Circumference
1
2019
35
0.160
Why?
Obesity, Abdominal
1
2019
19
0.160
Why?
Ventricular Function, Left
1
2019
45
0.160
Why?
Stroke Volume
1
2019
58
0.160
Why?
Natriuretic Peptide, Brain
1
2019
10
0.160
Why?
Drug Resistance, Neoplasm
1
2019
63
0.160
Why?
Infection Control
1
2020
166
0.160
Why?
American Heart Association
1
2018
18
0.150
Why?
Mouth
1
2018
15
0.150
Why?
Peptide Fragments
1
2019
77
0.150
Why?
Treatment Outcome
5
2021
3615
0.150
Why?
Bias
2
2008
41
0.150
Why?
Predictive Value of Tests
3
2019
492
0.150
Why?
Pharynx
1
2018
12
0.150
Why?
Coronavirus Infections
1
2020
90
0.150
Why?
Pneumonia, Viral
1
2020
94
0.150
Why?
Hemorrhage
1
2018
81
0.150
Why?
Glomerular Filtration Rate
1
2018
53
0.150
Why?
Pandemics
1
2020
260
0.150
Why?
Aspirin
1
2018
84
0.140
Why?
Plaque, Atherosclerotic
1
2017
4
0.140
Why?
Myocardial Infarction
1
2018
145
0.140
Why?
Caspases
1
2017
26
0.140
Why?
Coronary Vessels
1
2017
34
0.140
Why?
Tumor Cells, Cultured
1
2017
119
0.140
Why?
Signal Transduction
1
2019
447
0.140
Why?
Geriatric Assessment
1
2018
211
0.140
Why?
Exercise
1
2021
473
0.140
Why?
Blotting, Western
1
2017
148
0.140
Why?
Health Behavior
3
2021
165
0.140
Why?
Cohort Studies
2
2019
1926
0.130
Why?
Body Mass Index
1
2019
465
0.130
Why?
Telephone
2
2014
29
0.130
Why?
United States
3
2018
2201
0.130
Why?
Cross-Sectional Studies
1
2019
933
0.130
Why?
Patient Compliance
3
2016
164
0.120
Why?
Biomarkers, Tumor
1
2017
202
0.120
Why?
Calcium
1
2017
381
0.110
Why?
Depressive Disorder
2
2015
186
0.110
Why?
Elective Surgical Procedures
1
2013
39
0.110
Why?
Preoperative Care
1
2013
125
0.100
Why?
Heart Diseases
1
2013
71
0.100
Why?
New Zealand
3
2020
11
0.100
Why?
Evidence-Based Medicine
2
2011
196
0.090
Why?
Affect
1
2011
59
0.090
Why?
Family Practice
1
2009
15
0.080
Why?
Medical Audit
1
2009
6
0.080
Why?
Bayes Theorem
1
2009
43
0.080
Why?
Hospitals, Teaching
1
2009
31
0.080
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2009
25
0.080
Why?
Unnecessary Procedures
1
2009
30
0.080
Why?
Adrenergic beta-Antagonists
1
2009
29
0.080
Why?
Program Development
1
2009
64
0.080
Why?
Exercise Tolerance
2
2021
32
0.080
Why?
Electrocardiography
1
2009
119
0.080
Why?
Telemedicine
1
2011
121
0.080
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2009
61
0.080
Why?
Postoperative Complications
1
2013
932
0.070
Why?
Myocardial Revascularization
1
2006
18
0.070
Why?
Life Expectancy
1
2006
28
0.070
Why?
Incidence
2
2019
773
0.070
Why?
Cholesterol
2
2003
64
0.060
Why?
Survival Rate
1
2006
356
0.060
Why?
Time Factors
1
2009
1491
0.060
Why?
Hypercholesterolemia
2
2002
27
0.060
Why?
Follow-Up Studies
3
2018
1859
0.060
Why?
Immobilization
1
2023
14
0.050
Why?
Printing, Three-Dimensional
1
2023
9
0.050
Why?
Laryngectomy
1
2023
21
0.050
Why?
Neck
1
2023
26
0.050
Why?
Salvage Therapy
1
2023
35
0.050
Why?
Chemoradiotherapy
1
2023
61
0.050
Why?
Victoria
2
2019
8
0.050
Why?
Patient-Centered Care
1
2003
59
0.050
Why?
Radiotherapy Planning, Computer-Assisted
1
2023
68
0.050
Why?
Positron Emission Tomography Computed Tomography
1
2022
34
0.050
Why?
Cardiovascular Agents
2
2013
28
0.050
Why?
Biology
1
2022
8
0.050
Why?
Anticholesteremic Agents
1
2002
15
0.050
Why?
Ipilimumab
1
2021
4
0.050
Why?
Walk Test
1
2021
10
0.050
Why?
Early Medical Intervention
1
2021
15
0.050
Why?
Length of Stay
1
2023
329
0.050
Why?
Neoplasm Recurrence, Local
1
2022
206
0.050
Why?
Electrophoresis, Gel, Two-Dimensional
1
2020
10
0.050
Why?
Mass Spectrometry
1
2020
38
0.040
Why?
Cell Survival
1
2020
120
0.040
Why?
Pilot Projects
1
2022
440
0.040
Why?
Health Promotion
1
2002
162
0.040
Why?
Cell Line
1
2020
280
0.040
Why?
Recovery of Function
1
2021
300
0.040
Why?
Consensus
1
2020
98
0.040
Why?
Symptom Assessment
1
2019
20
0.040
Why?
Betacoronavirus
1
2020
77
0.040
Why?
Gene Expression Regulation
1
2020
281
0.040
Why?
Echocardiography
1
2019
114
0.040
Why?
Delivery of Health Care
1
2020
157
0.040
Why?
Tomography, X-Ray Computed
1
2022
730
0.040
Why?
ROC Curve
1
2019
144
0.040
Why?
Administration, Oral
1
2018
111
0.040
Why?
Treatment Failure
1
2018
163
0.040
Why?
Propensity Score
1
2017
36
0.040
Why?
Insurance, Health
1
2017
23
0.040
Why?
Sex Factors
1
2019
476
0.040
Why?
Double-Blind Method
1
2018
433
0.040
Why?
Cost-Benefit Analysis
1
2017
134
0.040
Why?
Survival Analysis
1
2017
267
0.040
Why?
Residence Characteristics
1
2019
214
0.030
Why?
Disease Management
1
2017
113
0.030
Why?
Patient Acceptance of Health Care
1
2017
81
0.030
Why?
Text Messaging
1
2016
16
0.030
Why?
Age Factors
1
2019
781
0.030
Why?
Single-Blind Method
1
2016
110
0.030
Why?
Case-Control Studies
1
2017
594
0.030
Why?
Independent Living
1
2018
318
0.030
Why?
Severity of Illness Index
1
2019
988
0.030
Why?
Anxiety
1
2015
161
0.030
Why?
Social Support
1
2015
217
0.030
Why?
Risk Adjustment
1
2013
11
0.030
Why?
Percutaneous Coronary Intervention
1
2013
25
0.030
Why?
Decision Support Techniques
1
2013
52
0.030
Why?
Health Status Indicators
1
2013
75
0.030
Why?
Hypolipidemic Agents
2
2003
28
0.030
Why?
Cardiac Surgical Procedures
1
2011
44
0.020
Why?
Clinical Protocols
1
2011
60
0.020
Why?
Feasibility Studies
1
2011
232
0.020
Why?
Cardiac Pacing, Artificial
1
2006
22
0.020
Why?
Aftercare
1
2006
26
0.020
Why?
Ventricular Dysfunction, Left
1
2006
46
0.020
Why?
Physical Examination
1
2006
118
0.020
Why?
Palliative Care
1
2006
109
0.020
Why?
Allied Health Personnel
1
2003
11
0.010
Why?
Nursing Staff, Hospital
1
2003
48
0.010
Why?
Europe
1
2002
66
0.010
Why?
Chi-Square Distribution
1
2002
146
0.010
Why?
Analysis of Variance
1
2002
269
0.010
Why?
Multivariate Analysis
1
2002
331
0.010
Why?
Diabetes Mellitus, Type 2
1
2002
191
0.010
Why?
Obesity
1
2002
321
0.010
Why?
Jelinek's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (241)
Explore
_
Co-Authors (14)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_